Diabetes and Other Diseases
648 articles
Maintenance Chemotherapy Trial for Pancreatic Cancer Patients with the BRCA Mutation
A clinical trial for patients with BRCA mutations uses a PARP inhibitor as part of the maintenance chemotherapy experimental treatment.
Early Detection Makes All the Difference
Carolynn Kiel lost her mother and sister to pancreatic cancer. Regular screening allowed early detection of her pancreatic cancer.
Facing Life’s Challenges
The first time John Sherry faced pancreatic cancer he had part of his pancreas removed; the second time he had a Whipple procedure.
A Heart Scan Finds Pancreatic Cancer
Barbara Washburn went for a heart scan because of a family history of heart disease. She never expected the scan to find neuroendocrine pancreatic cancer!
Juan Pellerano-Rendon
Juan Manuel Pellerano-Rendon IV is a first-generation American of Dominican and Colombian descent. He received his degree in Advertising, Marketing, and Sport Administration from the University of Miami. In his career, Juan has focused on the marketing and tech sectors, having worked at multiple advertising agencies and tech startups. He currently is an account director at […]
Exploring the Effectiveness of an Experimental Class of Drug
Does adding a PARP inhibitor drug to standard treatment help control the spread of advanced pancreatic cancer in patients with the BRCA mutation?
A New Chemotherapy and Radiation Regimen to Shrink Tumors Before Surgery
Researchers are testing a new combination of chemotherapies and radiation to shrink pancreatic cancer tumors and make surgical removal possible.
High-Dose Focused Radiation after Surgical Removal of Pancreatic Tumors
A clinical trial looks at the effectiveness of stereotactic body radiation therapy in killing cancer cells in the margins after pancreatic tumor removal.
Using a Vitamin to Make Low-Dose Chemotherapy More Effective
A clinical trial compares the effectiveness of low-dose continuous chemotherapy with and without high doses of vitamin C.
Testing Targeted Immunotherapy Against Pancreatic Cancer
Targeted immunotherapy is the focus of a clinical trial that tests the drug ibrutinib, approved for leukemia treatment, against pancreatic cancer.
Comparing a Standard Chemotherapy With and Without a PARP Inhibitor
A clinical trial compares standard chemotherapy with and without the addition of a PARP inihibitor, for patients whose pancreatic cancer is spreading again.
Two Types of Immunotherapy for Surgically Removable Pancreatic Cancer
A clinical trial compares the effectiveness of two different types of immunotherapy with standard treatment after pancreatic cancer surgery.
Presurgical Treatment for Pancreatic Cancer That Is Removable
A clinical trial looks at immunotherapy plus vitamin D plus standard chemotherapy before surgery to remove pancreatic cancer.
New Drug for BRCA Carriers with Advanced Cancer
A phase I clinical trial is testing the effectiveness of a platinum-based drug for BRCA carriers with pancreatic, breast, and other cancers.
Testing an Experimental Combination of Drugs
A clinical trial for some cancers including pancreatic cancer tests the effectiveness of a checkpoint inhibitor and an antisense oligonucleotide inhibitor.